Systemic therapeutic agents and glaucoma.
D000470:Alkaloids / Q000009:adverse effects; D000661:Amphetamine / Q000009:adverse effects; D000867:Anterior Chamber / Q000033:anatomy & histology; D000886:Anthropometry; D000978:Antiparkinson Agents / Q000009:adverse effects; D001532:Atropa belladonna / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005901:Glaucoma / Q000139:chemically induced* / Q000151:congenital / Q000175:diagnosis; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009887:Ophthalmoscopy; D010276:Parasympatholytics / Q000009:adverse effects; D010946:Plants, Medicinal; D010947:Plants, Toxic; D013566:Sympathomimetics / Q000009:adverse effects
D000470:Alkaloids; D000978:Antiparkinson Agents; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D013566:Sympathomimetics; D000661:Amphetamine